000 | 01230 a2200313 4500 | ||
---|---|---|---|
005 | 20250514225652.0 | ||
264 | 0 | _c20060905 | |
008 | 200609s 0 0 eng d | ||
022 | _a0031-6970 | ||
024 | 7 |
_a10.1007/s00228-005-0913-x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZehngawa, W | |
245 | 0 | 0 |
_aRelationship between calcineurin inhibition and plasma endothelin concentrations in cyclosporine-A-treated kidney transplant patients--a comment. _h[electronic resource] |
260 |
_bEuropean journal of clinical pharmacology _cJun 2005 |
||
300 |
_a317 p. _bdigital |
||
500 | _aPublication Type: Comment; Letter | ||
650 | 0 | 4 |
_aAntihypertensive Agents _xpharmacology |
650 | 0 | 4 |
_aCalcineurin _xblood |
650 | 0 | 4 | _aCalcineurin Inhibitors |
650 | 0 | 4 |
_aCyclosporine _xadverse effects |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 |
_aEndothelins _xblood |
650 | 0 | 4 |
_aGingival Hypertrophy _xchemically induced |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
650 | 0 | 4 | _aKidney Transplantation |
773 | 0 |
_tEuropean journal of clinical pharmacology _gvol. 61 _gno. 4 _gp. 317 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00228-005-0913-x _zAvailable from publisher's website |
999 |
_c15554492 _d15554492 |